ROYAL OAK, Mich., Sept 23, 2008 /PRNewswire via COMTEX/ -- The Beaumont Commercialization Center, a medical device development company within Beaumont Hospitals, has a new surgical instrument available for licensing.
Paul J. Arpasi, M.D., a Beaumont radiologist, developed a device that will help reduce the risk for excessive bleeding and infection by allowing multiple catheters or other devices to be connected to a patient from a single puncture site.
When treating a patient, there is often a need to use more than one type of drug or medical device. This creates a need for more than one access site. Any time an access site is used, there is increased risk for excessive bleeding and infection, so it is ideal to keep the number of access sites to a minimum.
This new device has multiple access ports that allow thrombolytic catheters or other devices, such as wires, snares, and low-profile angioplasty balloons to be simultaneously connected to a patient through a single puncture site.
"The need to insert multiple devices or deliver more than one type of drug to a patient is very common and this invention helps to make that faster, easier, and less invasive," said Dr. Arpasi. "I'm grateful for the opportunity to improve this procedure and to help in reducing patient's risk of complications."
For licensing information, contact Mike Tanner, Director of Technology Development, at (248) 551-0567 or email him at firstname.lastname@example.org. For additional information on this and other licensing opportunities from the Beaumont Commercialization Center, please visit www.BeaumontCommercializationCenter.com